A S Al-Smadi1, R N Abdalla1,2, A H Elmokadem1,3, A Shaibani1,4, M C Hurley1,4, M B Potts1,4, B S Jahromi1,4, T J Carroll5, S A Ansari6,7,4. 1. From the Departments of Radiology (A.S.A.-S., R.N.A., A.H.E., A.S., M.C.H., M.B.P., B.S.J., S.A.A.). 2. Department of Radiology (R.N.A.), Ain Shams University, Cairo, Egypt. 3. Department of Radiology (A.H.E.), Mansoura University, Mansoura, Egypt. 4. Neurological Surgery (A.S., M.C.H., M.B.P., B.S.J., S.A.A.), Northwestern University, Feinberg School of Medicine, Chicago, Illinois. 5. Department of Radiology (T.J.C.), University of Chicago, Chicago, Illinois. 6. From the Departments of Radiology (A.S.A.-S., R.N.A., A.H.E., A.S., M.C.H., M.B.P., B.S.J., S.A.A.) s-ansari@northwestern.edu. 7. Neurology (S.A.A.).
Abstract
BACKGROUND AND PURPOSE: 3D high-resolution black-blood MRI or MR vessel wall imaging allows evaluation of the intracranial arterial wall and extraluminal pathology. We investigated the diagnostic accuracy and reliability of black-blood MRI for the intraluminal detection of large-vessel arterial occlusions. MATERIALS AND METHODS: We retrospectively identified patients with intracranial arterial occlusions, confirmed by CTA or DSA, who also underwent 3D black-blood MRI with nonenhanced and contrast-enhanced T1 sampling perfection with application-optimized contrasts by using different flip angle evolution (T1 SPACE) sequences. Black-blood MRI findings were evaluated by 2 independent and blinded neuroradiologists. Large-vessel intracranial arterial segments were graded on a 3-point scale (grades 0-2) for intraluminal baseline T1 hyperintensity and contrast enhancement. Vessel segments were considered positive for arterial occlusion if focal weak (grade 1) or strong (grade 2) T1-hyperintense signal and/or enhancement replaced the normal intraluminal black-blood signal. RESULTS: Thirty-one patients with 38 intracranial arterial occlusions were studied. The median time interval between black-blood MRI and CTA/DSA reference standard studies was 2 days (range, 0-20 days). Interobserver agreement was good for T1 hyperintensity (κ = 0.63) and excellent for contrast enhancement (κ = 0.89). High sensitivity (100%) and specificity (99.8%) for intracranial arterial occlusion diagnosis was observed with either intraluminal T1 hyperintensity or contrast-enhancement imaging criteria on black-blood MRI. Strong grade 2 intraluminal enhancement was maintained in >80% of occlusions irrespective of location or chronicity. Relatively increased strong grade 2 intraluminal T1 hyperintensity was noted in chronic/incidental versus acute/subacute occlusions (45.5% versus 12.5%, P = .04). CONCLUSIONS: Black-blood MRI with or without contrast has high diagnostic accuracy and reliability in evaluating intracranial large-vessel arterial occlusions with near-equivalency to DSA and CTA.
BACKGROUND AND PURPOSE: 3D high-resolution black-blood MRI or MR vessel wall imaging allows evaluation of the intracranial arterial wall and extraluminal pathology. We investigated the diagnostic accuracy and reliability of black-blood MRI for the intraluminal detection of large-vessel arterial occlusions. MATERIALS AND METHODS: We retrospectively identified patients with intracranial arterial occlusions, confirmed by CTA or DSA, who also underwent 3D black-blood MRI with nonenhanced and contrast-enhanced T1 sampling perfection with application-optimized contrasts by using different flip angle evolution (T1 SPACE) sequences. Black-blood MRI findings were evaluated by 2 independent and blinded neuroradiologists. Large-vessel intracranial arterial segments were graded on a 3-point scale (grades 0-2) for intraluminal baseline T1 hyperintensity and contrast enhancement. Vessel segments were considered positive for arterial occlusion if focal weak (grade 1) or strong (grade 2) T1-hyperintense signal and/or enhancement replaced the normal intraluminal black-blood signal. RESULTS: Thirty-one patients with 38 intracranial arterial occlusions were studied. The median time interval between black-blood MRI and CTA/DSA reference standard studies was 2 days (range, 0-20 days). Interobserver agreement was good for T1 hyperintensity (κ = 0.63) and excellent for contrast enhancement (κ = 0.89). High sensitivity (100%) and specificity (99.8%) for intracranial arterial occlusion diagnosis was observed with either intraluminal T1 hyperintensity or contrast-enhancement imaging criteria on black-blood MRI. Strong grade 2 intraluminal enhancement was maintained in >80% of occlusions irrespective of location or chronicity. Relatively increased strong grade 2 intraluminal T1 hyperintensity was noted in chronic/incidental versus acute/subacute occlusions (45.5% versus 12.5%, P = .04). CONCLUSIONS: Black-blood MRI with or without contrast has high diagnostic accuracy and reliability in evaluating intracranial large-vessel arterial occlusions with near-equivalency to DSA and CTA.
Authors: Mai N Nguyen-Huynh; Max Wintermark; Joey English; Jack Lam; Eric Vittinghoff; Wade S Smith; S Claiborne Johnston Journal: Stroke Date: 2008-02-21 Impact factor: 7.914
Authors: P Vakil; J Vranic; M C Hurley; R A Bernstein; A W Korutz; A Habib; A Shaibani; F H Dehkordi; T J Carroll; S A Ansari Journal: AJNR Am J Neuroradiol Date: 2013-07-04 Impact factor: 3.825
Authors: Y Korogi; M Takahashi; N Mabuchi; H Miki; H Shiga; T Watabe; T O'Uchi; T Nakagawa; Y Horikawa; S Fujiwara Journal: Radiology Date: 1994-10 Impact factor: 11.105
Authors: N J Lee; M S Chung; S C Jung; H S Kim; C-G Choi; S J Kim; D H Lee; D C Suh; S U Kwon; D-W Kang; J S Kim Journal: AJNR Am J Neuroradiol Date: 2016-09-22 Impact factor: 3.825
Authors: Ferdinand K Hui; Xianjin Zhu; Stephen E Jones; Ken Uchino; Jennifer A Bullen; M Shazam Hussain; Xin Lou; Wei-Jian Jiang Journal: J Neurointerv Surg Date: 2014-05-14 Impact factor: 5.836
Authors: Qi Liu; Jun Huang; Andrew J Degnan; Shiyue Chen; Jonathan H Gillard; Zhongzhao Teng; Jianping Lu Journal: Int J Cardiovasc Imaging Date: 2013-05-19 Impact factor: 2.357
Authors: M Wan; L Yan; Z Xu; Z Hou; K Kang; R Cui; Y Yu; J Song; F K Hui; Y Wang; Z Miao; X Lou; N Ma Journal: AJNR Am J Neuroradiol Date: 2021-12-02 Impact factor: 3.825
Authors: Marta Bertamino; Sara Signa; Marco Veneruso; Giulia Prato; Roberta Caorsi; Giuseppe Losurdo; Federica Teutonico; Silvia Esposito; Francesca Formica; Nicola Tovaglieri; Maria A Nagel; Giulia Amico; Alice Zanetti; Domenico Tortora; Andrea Rossi; Paolo Moretti; Marco Gattorno; Angelo Ravelli; Mariasavina Severino Journal: J Neurol Date: 2021-05-27 Impact factor: 6.682